Balaji Amines posted good Q2 earnings. The company has seen top down growth this quarter. It has been a 24 percent revenue growth and a 63 percent EBITDA growth.
D Ram Reddy, MD of Balaji Amines said, “Because of this Atmanirbhar Bharat entire specialty chemical industry will be at advantageous stage. Lot of pharma and API industries have planned for their expansion. We are the main raw materials suppliers to the API and pharma industry so we will definitely be having the good growth.”
To know more about the company's Q2 performance, watch the video.